Skip to the page

Data / Drug companies / Kalintis Healthcare Private Limited

Kalintis Healthcare Private Limited: 18 products in the FDA NDC directory, labeler code 72166

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Kalintis Healthcare Private Limited (labeler code 72166) lists 18 products in the FDA National Drug Code Directory. By type: 18 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 7, 2025.

The request: Watch Kalintis Healthcare Private Limited (FDA labeler code 72166): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72166
Products in commercial distribution
18
Packages
19
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule II 2, Schedule III 1, Schedule IV 3
Started marketing in the last 12 months
0
Earliest marketing start
March 14, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients1794.4%
Bulk ingredients for compounding15.6%

Products by type

TypeProductsShare
Bulk ingredients18100%

Dosage forms

Dosage formProductsShare
Powder1794.4%
Liquid15.6%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ferric carboxymaltose72166-026PowderBulk ingredientsFebruary 7, 2025
Phenobarbital72166-025PowderBulk ingredientsFebruary 7, 2025
Methylene blue72166-023PowderBulk ingredientsFebruary 7, 2025
Valproic acid72166-022LiquidBulk ingredientsAugust 2, 2024
Ketotifen fumarate72166-021PowderBulk ingredientsAugust 2, 2024
Butalbital72166-020PowderBulk ingredientsAugust 2, 2024
Promethazine hydrochloride72166-019PowderBulk ingredientsDecember 20, 2023
Esomeprazole magnesium trihydrate72166-017PowderBulk ingredientsApril 12, 2023
Diphenoxylate hydrochloride and atropine sulfate72166-013PowderBulk ingredients for compoundingMarch 3, 2021
Cevimeline hydrochloride72166-012PowderBulk ingredientsMarch 3, 2021
Diphenoxylate hydrochloride72166-011PowderBulk ingredientsMarch 3, 2021
Torsemide72166-010PowderBulk ingredientsAugust 8, 2020
Oxazepam72166-009PowderBulk ingredientsAugust 8, 2020
Mexiletine hydrochloride72166-007PowderBulk ingredientsApril 11, 2019
Benztropine mesylate72166-005PowderBulk ingredientsApril 9, 2018
Chlorpromazine hydrochloride72166-004PowderBulk ingredientsApril 9, 2018
Lorazepam72166-001PowderBulk ingredientsApril 9, 2018
Furosemide72166-003PowderBulk ingredientsMarch 14, 2018

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.